Israeli researchers develop promising new blood cancer treatment
Israeli patients suffering from multiple myeloma (a cancer of white blood cell) or amyloidosis (in which abnormal proteins build up in tissue) have improved or gone into remission with an experimental treatment of CAR-T positive cells. The medical technology – called HBI0101, anti-BCMA CAR-T cells –was given as part of an ongoing Phase 1b clinical […]
Continue Reading